Baseline OCT Measurements in the Idiopathic Intracranial Hypertension Treatment Trial, Part II: Correlations and Relationship to Clinical Features

被引:75
|
作者
Auinger, Peggy [1 ]
Durbin, Mary
Feldon, Steven [1 ]
Garvin, Mona [2 ]
Kardon, Randy [2 ]
Keltner, John [3 ]
Kupersmith, Mark J. [4 ,5 ]
Sibony, Patrick [6 ]
Plumb, Kim [3 ]
Wang, Jui-Kai [2 ]
Werner, John S. [3 ]
机构
[1] Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA
[2] Univ Iowa, Iowa City, IA 52242 USA
[3] Univ Calif Davis, Davis, CA 95616 USA
[4] St Lukes Roosevelt Hosp, New York, NY USA
[5] New York Eye & Ear Infirm, New York, NY USA
[6] SUNY Stony Brook, Stony Brook, NY 11794 USA
关键词
papilledema; intracranial hypertension; OCT; lumbar puncture; OPTICAL COHERENCE TOMOGRAPHY; PAPILLEDEMA; PRESSURE; NERVE;
D O I
10.1167/iovs.14-14961
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. The accepted method to evaluate and monitor papilledema, Frisen grading, uses an ordinal approach based on descriptive features. Part I showed that spectral-domain optical coherence tomography (SD-OCT) in a clinical trial setting provides reliable measurement of the effects of papilledema on the optic nerve head (ONH) and peripapillary retina, particularly if a 3-D segmentation method is used for analysis. 1 We evaluated how OCT parameters are interrelated and how they correlate with vision and other clinical features in idiopathic intracranial hypertension (IIH) patients. METHODS. A total of 126 subjects in the IIH Treatment Trial (IIHTT) OCT substudy had Cirrus SD-OCT optic disc and macula scans analyzed by using a 3-D segmentation algorithm to derive retinal nerve fiber layer (RNFL) thickness, total retinal thickness (TRT), retinal ganglion cell layer plus inner plexiform layer (GCL+IPL) thickness, and ONH volume. The SD-OCT parameter values were correlated with high-and low-contrast acuity, perimetric mean deviation, Frisen grading, and IIH features. RESULTS. At study entry, the average RNFL thickness, TRT, and ONH volume showed significant strong correlations (r >= 0.90) with each other. The same OCT parameters showed a strong (r > 0.76) correlation with Frisen grade and a mild (r > 0.24), but significant, correlation with lumbar puncture opening pressure. For all eyes at baseline, neither visual acuity (high or low contrast) nor mean deviation correlated with any OCT measure of swelling or GCL+IPL thickness. CONCLUSIONS. In newly diagnosed IIH, OCT demonstrated alterations of the peripapillary retina and ONH correlate with Frisen grading of papilledema. At presentation, OCT measures of papilledema, in patients with newly diagnosed IIH and mild vision loss, do not correlate with clinical features or visual dysfunction.
引用
收藏
页码:8173 / 8179
页数:7
相关论文
共 50 条
  • [31] Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss The Idiopathic Intracranial Hypertension Treatment Trial
    Wall, Michael
    McDermott, Michael P.
    Kieburtz, Karl D.
    Corbett, James J.
    Feldon, Steven E.
    Friedman, Deborah I.
    Katz, David M.
    Keltner, John L.
    Schron, Eleanor B.
    Kupersmith, Mark J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (16): : 1641 - 1651
  • [32] Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension)
    Brazis, P. W.
    CEPHALALGIA, 2008, 28 (12) : 1361 - 1373
  • [33] Characterization of Ocular Sonography Findings and their Relationship to Clinical Features from a South Indian Cohort of Idiopathic Intracranial Hypertension
    Kishore, K., V
    Patwardhan, Ameya
    Aravinda, H. R.
    Mustare, Veerendrakumar
    Ramakrishnan, Subasree
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2024, 27 (02) : 146 - 151
  • [34] Papilledema Outcome Evaluation in the OCT Substudy of theIdiopathic Intracranial Hypertension Treatment Trial
    Kupersmith, Mark J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [35] Primary Outcome Results of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)
    Friedman, D., I
    HEADACHE, 2014, 54 : 10 - 11
  • [36] Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)
    Wall, Michael
    Johnson, Chris A.
    Cello, Kimberly E.
    Zamba, K. D.
    McDermott, Michael P.
    Keltner, John L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (03) : 805 - 812
  • [37] Headaches in the Idiopathic Intracranial Hypertension Treatment Trial: Six Month Outcomes
    Friedman, Deborah I.
    Quiros, Peter
    Subramanian, Prem
    Mejico, Luis J.
    McDermott, Michael
    CEPHALALGIA, 2017, 37 : 19 - 20
  • [38] Pointwise Visual Field Change in the Idiopathic Intracranial Hypertension Treatment Trial
    Wall, Michael
    Zamba, Gideon
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [39] Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial
    Bruce, Beau B.
    Digre, Kathleen B.
    McDermott, Michael P.
    Schron, Eleanor B.
    Wall, Michael
    NEUROLOGY, 2016, 87 (18) : 1871 - 1877
  • [40] Retinal Vessel Tortuosity Indices (VTIs) as a potential biomarker of idiopathic intracranial hypertension(IIH): Baseline analysis of the IIH treatment trial
    Buickians, David
    Dahshan, Deena
    Shahidi, Mahnaz
    Nankali, Amir
    Feldon, Steven E.
    Moss, Heather
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)